Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

B Wang, L Wu, J Chen, L Dong, C Chen… - Signal transduction and …, 2021 - nature.com
The arachidonic acid (AA) pathway plays a key role in cardiovascular biology,
carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified …

Drug metabolism in the liver

OA Almazroo, MK Miah… - Clinics in liver …, 2017 - liver.theclinics.com
Drugs are typically small molecules that are generally classified as xenobiotics, which are
foreign to the human body. Several endogenous molecules, however, such as steroids and …

[HTML][HTML] Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation

UM Zanger, M Schwab - Pharmacology & therapeutics, 2013 - Elsevier
Cytochromes P450 (CYP) are a major source of variability in drug pharmacokinetics and
response. Of 57 putatively functional human CYPs only about a dozen enzymes, belonging …

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

M Martignoni, GMM Groothuis… - Expert opinion on drug …, 2006 - Taylor & Francis
Animal models are commonly used in the preclinical development of new drugs to predict
the metabolic behaviour of new compounds in humans. It is, however, important to realise …

[HTML][HTML] Animal models to study bile acid metabolism

J Li, PA Dawson - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2019 - Elsevier
The use of animal models, particularly genetically modified mice, continues to play a critical
role in studying the relationship between bile acid metabolism and human liver disease …

Genetic variants associated with phenytoin-related severe cutaneous adverse reactions

WH Chung, WC Chang, YS Lee, YY Wu, CH Yang… - Jama, 2014 - jamanetwork.com
Importance The antiepileptic drug phenytoin can cause cutaneous adverse reactions,
ranging from maculopapular exanthema to severe cutaneous adverse reactions, which …

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

UM Zanger, M Turpeinen, K Klein… - Analytical and bioanalytical …, 2008 - Springer
We investigated the elimination routes for the 200 drugs that are sold most often by
prescription count in the United States. The majority (78%) of the hepatically cleared drugs …

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data

CR Lee, JA Goldstein, JA Pieper - Pharmacogenetics and …, 2002 - journals.lww.com
The discovery of six distinct polymorphisms in the genetic sequence encoding for the
cytochrome P450 2C9 (CYP2C9) protein has stimulated numerous investigations in an …

Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding

A Barkun, M Bardou, JK Marshall… - Annals of internal …, 2003 - acpjournals.org
Background: The management of patients with acute nonvariceal upper gastrointestinal
bleeding has evolved substantially over the past 10 years amid a paucity of published …

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

D Sibbing, J Stegherr, W Latz, W Koch… - European heart …, 2009 - academic.oup.com
Aims Several studies have demonstrated that the mutant* 2 allele of the CYP2C19 681G> A
loss-of-function polymorphism is associated with diminished metabolization of clopidogrel …